Ebola had just killed thousands of people in Liberia, and the US-backed pitch to sign locals up for a vaccine trial must have seemed like a tough sell: Take part of the very virus that had devastated the region, combine it with a separate, harmless virus, and inject it into volunteers with the hope they develop Ebola antibodies.
Read complete report here.
